
    
      -  To assess the quality of anticoagulation with warfarin in real world practice of Korea
           for secondary stroke prevention in patients with AF-related Cardioembolic (CE) stroke 1)
           who initiated warfarin therapy and treatment at least for more than 7 days of warfarin
           adjustment period (warfarin-initiated cohort), and 2) who initiated and maintained
           warfarin therapy at least for more than 90 days after the 7 days of warfarin adjustment
           period (long-term warfarin-treated cohort).

        -  To explore predictors for poor INR control.
    
  